Guillain-Barré syndrome laboratory tests: Difference between revisions

Jump to navigation Jump to search
m (Changes made per Mahshid's request)
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
Guillain-Barré syndrome is usually diagnosed clinically. Lab tests are done to exclude other diagnosis and assess prognosis. The lab tests ordered are basic labs ([[CBC]], [[ESR]]), lumbar puncture (GBS has characteristic albuminocytological dissociation)and serological markers.


==Laboratory Findings==
==Laboratory Findings==
===Routine Labs===
* [[Complete blood count]] + [[ESR]] (increased in inflammatory process)
* [[Serum electrolytes]]
* [[Liver function test]]
* Creatinine kinase increased in [[inflammation]] and [[myopathies]]
* Stool culture for ''[[campylobacter jejuni]]'' (less frequent)
===Cerebrospinal Analysis===
* CSF is used almost every time to verify symptoms, but because of the acute nature of the disease, they may not become abnormal until after the first week of onset of signs and symptoms.
* Typical CSF findings include an elevated protein level (100 - 1000 mg/dL) without an accompanying pleocytosis (increased cell count) (albuminocytological dissociation in the CSF). A sustained pleocytosis may indicate an alternative diagnosis such as infection
* On contrary Guillian Barre syndrome in [[HIV]] patients have CSF pleocytosis
* In 1 in 10 patients with GBS, the CSF protein may not be elevated.
===Serology===
* Less frequently done for ''[[campylobacter jejuni]]'', [[CMV]], [[EBV]], [[HSV]], [[HIV]] and [[mycoplasma pneumonia]].
* Autoantibodies are only measured in case the diagnosis of GBS is uncertain. Antibodies to glycolipids, anti GM1 antibodies and Anti-GQ1b are increased.
====Peripheral Neuropathy Panel====
A panel of tests can be ordered in cases of diagnostic uncertainty with other peripheral neuropathies
* [[Vitamin B12]], [[folic acid]]
* Thyroid profile (to rule out thyroid neuropathies)
* [[Erythrocyte sedimentation rate]] (ESR)increased in inflammatory process
* [[Rapid protein reagent]] for [[syphilis]]
* Rheumatology profiles
* Hemoglobin A1c for [[diabetic neuropathy]]
* Immunoelectrophoresis for serum protein ([[multiple myeloma]])
* [[Heavy metal poisoning]]


==References==
==References==

Revision as of 19:29, 17 December 2018

Guillain-Barré syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Guillain-Barré syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural history, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Guillain-Barré syndrome laboratory tests On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Guillain-Barré syndrome laboratory tests

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Guillain-Barré syndrome laboratory tests

CDC on Guillain-Barré syndrome laboratory tests

Guillain-Barré syndrome laboratory tests in the news

Blogs on Guillain-Barré syndrome laboratory tests

Directions to Hospitals Treating Guillain-Barré syndrome

Risk calculators and risk factors for Guillain-Barré syndrome laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Priyamvada Singh, MBBS [2]

Overview

Laboratory Findings

References

Template:WH Template:WS